메뉴 건너뛰기




Volumn 9, Issue 1, 2016, Pages

Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34+ cells of juvenile myelomonocytic leukemia

Author keywords

Chimeric antigen receptor; GM CSF receptor; Juvenile myelomonocytic leukemia; Leukemic stem cells; piggyBac transposon

Indexed keywords

CD34 ANTIGEN; CHIMERIC ANTIGEN RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; STEM CELL FACTOR; THROMBOPOIETIN; HYBRID PROTEIN; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR;

EID: 85007553986     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/s13045-016-0256-3     Document Type: Article
Times cited : (42)

References (30)
  • 1
    • 43449083229 scopus 로고    scopus 로고
    • Recent advances in the pathogenesis and management of juvenile myelomonocytic leukemia
    • Koike K, Matsuda K. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukemia. Br J Haematol. 2008;141:567-75.
    • (2008) Br J Haematol. , vol.141 , pp. 567-575
    • Koike, K.1    Matsuda, K.2
  • 2
    • 84906076393 scopus 로고    scopus 로고
    • Juvenile myelomonocytic leukemia: Molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation
    • Dvorak CC, Loh ML. Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation. Front Pediatr. 2014;2:1-8.
    • (2014) Front Pediatr. , vol.2 , pp. 1-8
    • Dvorak, C.C.1    Loh, M.L.2
  • 3
    • 84881020319 scopus 로고    scopus 로고
    • Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia
    • Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet. 2013;45:937-41.
    • (2013) Nat Genet. , vol.45 , pp. 937-941
    • Sakaguchi, H.1    Okuno, Y.2    Muramatsu, H.3    Yoshida, K.4    Shiraishi, Y.5    Takahashi, M.6
  • 4
    • 84904063832 scopus 로고    scopus 로고
    • Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia
    • Matsuda K, Nakazawa Y, Iwashita C, Kurata T, Hirabayashi K, Saito S, et al. Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia. Leukemia. 2014;287:1545-8.
    • (2014) Leukemia. , vol.287 , pp. 1545-1548
    • Matsuda, K.1    Nakazawa, Y.2    Iwashita, C.3    Kurata, T.4    Hirabayashi, K.5    Saito, S.6
  • 5
    • 84926688835 scopus 로고    scopus 로고
    • Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia
    • Stieglitz E, Troup CB, Gelston LC, Haliburton J, Chow ED, Yu KB, et al. Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia. Blood. 2015;125:516-24.
    • (2015) Blood. , vol.125 , pp. 516-524
    • Stieglitz, E.1    Troup, C.B.2    Gelston, L.C.3    Haliburton, J.4    Chow, E.D.5    Yu, K.B.6
  • 6
    • 84945484387 scopus 로고    scopus 로고
    • Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network
    • Caye A, Strullu M, Guidez F, Cassinat B, Gazal S, Fenneteau O, et al. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. Nat Genet. 2015;47:1334-40.
    • (2015) Nat Genet. , vol.47 , pp. 1334-1340
    • Caye, A.1    Strullu, M.2    Guidez, F.3    Cassinat, B.4    Gazal, S.5    Fenneteau, O.6
  • 7
    • 84923301480 scopus 로고    scopus 로고
    • How i treat juvenile myelomonocytic leukemia
    • Locatelli F, Niemeyer CM. How I treat juvenile myelomonocytic leukemia. Blood. 2015;125:1083-90.
    • (2015) Blood. , vol.125 , pp. 1083-1090
    • Locatelli, F.1    Niemeyer, C.M.2
  • 8
    • 0037369296 scopus 로고    scopus 로고
    • Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion
    • Worth A, Rao K, Webb D, Chessells J, Passmore J, Veys P. Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion. Blood. 2003;101:1713-4.
    • (2003) Blood. , vol.101 , pp. 1713-1714
    • Worth, A.1    Rao, K.2    Webb, D.3    Chessells, J.4    Passmore, J.5    Veys, P.6
  • 9
    • 20044393759 scopus 로고    scopus 로고
    • Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia
    • Yoshimi A, Bader P, Matthes-Martin S, Starý J, Sedlacek P, Duffner U, et al. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia. 2005;19:971-7.
    • (2005) Leukemia. , vol.19 , pp. 971-977
    • Yoshimi, A.1    Bader, P.2    Matthes-Martin, S.3    Starý, J.4    Sedlacek, P.5    Duffner, U.6
  • 10
    • 0141502162 scopus 로고    scopus 로고
    • Generation of immunostimulatory dendritic cells from the malignant clone in patients with juvenile myelomonocytic leukemia
    • Nabarro S, Thrasher AJ, Kempski H, Amrolia P, Anderson J. Generation of immunostimulatory dendritic cells from the malignant clone in patients with juvenile myelomonocytic leukemia. Leukemia. 2003;17:1910-2.
    • (2003) Leukemia. , vol.17 , pp. 1910-1912
    • Nabarro, S.1    Thrasher, A.J.2    Kempski, H.3    Amrolia, P.4    Anderson, J.5
  • 11
    • 33749324960 scopus 로고    scopus 로고
    • Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia
    • Hirano N, Butler MO, Xia Z, Berezovskaya A, Murray AP, Ansén S, et al. Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia. Blood. 2006;108:2662-8.
    • (2006) Blood. , vol.108 , pp. 2662-2668
    • Hirano, N.1    Butler, M.O.2    Xia, Z.3    Berezovskaya, A.4    Murray, A.P.5    Ansén, S.6
  • 14
    • 84923019006 scopus 로고    scopus 로고
    • T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukemia in children and young adults: A phase 1 doseescalation trial
    • Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA, et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukemia in children and young adults: A phase 1 doseescalation trial. Lancet. 2015;385:517-28.
    • (2015) Lancet. , vol.385 , pp. 517-528
    • Lee, D.W.1    Kochenderfer, J.N.2    Stetler-Stevenson, M.3    Cui, Y.K.4    Delbrook, C.5    Feldman, S.A.6
  • 15
    • 84905440832 scopus 로고    scopus 로고
    • Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
    • Saito S, Nakazawa Y, Sueki A, Matsuda K, Tanaka M, Yanagisawa R, et al. Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Cytotherapy. 2014;16:1257-69.
    • (2014) Cytotherapy. , vol.16 , pp. 1257-1269
    • Saito, S.1    Nakazawa, Y.2    Sueki, A.3    Matsuda, K.4    Tanaka, M.5    Yanagisawa, R.6
  • 16
    • 82955195419 scopus 로고    scopus 로고
    • Combining mTor inhibitors with rapamycin-resistant T cells: A two-pronged approach to tumor elimination
    • Huye LE, Nakazawa Y, Patel MP, Yvon E, Sun J, Savoldo B, et al. Combining mTor inhibitors with rapamycin-resistant T cells: A two-pronged approach to tumor elimination. Mol Ther. 2011;19:2239-48.
    • (2011) Mol Ther. , vol.19 , pp. 2239-2248
    • Huye, L.E.1    Nakazawa, Y.2    Patel, M.P.3    Yvon, E.4    Sun, J.5    Savoldo, B.6
  • 17
    • 84924373043 scopus 로고    scopus 로고
    • In vitro expansion of CD34+CD38- cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia
    • Sakashita K, Kato I, Daifu T, Saida S, Hiramatsu H, Nishinaka Y, et al. In vitro expansion of CD34+CD38- cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia. Leukemia. 2015;29:606-14.
    • (2015) Leukemia. , vol.29 , pp. 606-614
    • Sakashita, K.1    Kato, I.2    Daifu, T.3    Saida, S.4    Hiramatsu, H.5    Nishinaka, Y.6
  • 18
    • 78649899281 scopus 로고    scopus 로고
    • Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: Improvement of their immune activity by expression of CD33-specific chimeric receptors
    • Marin V, Pizzitola I, Agostoni V, Attianese GM, Finney H, Lawson A, et al. Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors. Haematologica. 2010;95:2144-52.
    • (2010) Haematologica. , vol.95 , pp. 2144-2152
    • Marin, V.1    Pizzitola, I.2    Agostoni, V.3    Attianese, G.M.4    Finney, H.5    Lawson, A.6
  • 19
    • 84888226232 scopus 로고    scopus 로고
    • T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
    • Mardiros A, Dos Santos C, McDonald T, Brown CE, Wang X, Budde LE, et al. T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia. Blood. 2013;122:3138-48.
    • (2013) Blood. , vol.122 , pp. 3138-3148
    • Mardiros, A.1    Dos Santos, C.2    McDonald, T.3    Brown, C.E.4    Wang, X.5    Budde, L.E.6
  • 20
    • 84905714921 scopus 로고    scopus 로고
    • Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
    • Pizzitola I, Anjos-Afonso F, Rouault-Pierre K, Lassailly F, Tettamanti S, Spinelli O, et al. Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo. Leukemia. 2014;28:1596-605.
    • (2014) Leukemia. , vol.28 , pp. 1596-1605
    • Pizzitola, I.1    Anjos-Afonso, F.2    Rouault-Pierre, K.3    Lassailly, F.4    Tettamanti, S.5    Spinelli, O.6
  • 21
    • 84901703340 scopus 로고    scopus 로고
    • Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
    • Gill S, Tasian SK, Ruella M, Shestova O, Li Y, Porter DL, et al. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells. Blood. 2014;123:2343-54.
    • (2014) Blood. , vol.123 , pp. 2343-2354
    • Gill, S.1    Tasian, S.K.2    Ruella, M.3    Shestova, O.4    Li, Y.5    Porter, D.L.6
  • 22
    • 0032400865 scopus 로고    scopus 로고
    • Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia
    • Frankel AE, Lilly M, Kreitman R, Hogge D, Beran M, Freedman MH, et al. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia. Blood. 1998;92:4279-86.
    • (1998) Blood. , vol.92 , pp. 4279-4286
    • Frankel, A.E.1    Lilly, M.2    Kreitman, R.3    Hogge, D.4    Beran, M.5    Freedman, M.H.6
  • 23
    • 34250017142 scopus 로고    scopus 로고
    • Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations
    • Matsuda K, Shimada A, Yoshida N, Ogawa A, Watanabe A, Yajima S, et al. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood. 2007;109:5477-80.
    • (2007) Blood. , vol.109 , pp. 5477-5480
    • Matsuda, K.1    Shimada, A.2    Yoshida, N.3    Ogawa, A.4    Watanabe, A.5    Yajima, S.6
  • 24
    • 61949288688 scopus 로고    scopus 로고
    • Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia
    • Yoshida N, Yagasaki H, Xu Y, Matsuda K, Yoshimi A, Takahashi Y, et al. Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia. Pediatr Res. 2009;65:334-40.
    • (2009) Pediatr Res. , vol.65 , pp. 334-340
    • Yoshida, N.1    Yagasaki, H.2    Xu, Y.3    Matsuda, K.4    Yoshimi, A.5    Takahashi, Y.6
  • 25
    • 84984935016 scopus 로고    scopus 로고
    • Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
    • Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet. 2010;42:794-800.
    • (2010) Nat Genet. , vol.42 , pp. 794-800
    • Niemeyer, C.M.1    Kang, M.W.2    Shin, D.H.3    Furlan, I.4    Erlacher, M.5    Bunin, N.J.6
  • 26
    • 84860838806 scopus 로고    scopus 로고
    • Long-term hematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukemia and poor correlation with adult myelodysplasia spliceosome-related mutations
    • Matsuda K, Yoshida N, Miura S, Nakazawa Y, Sakashita K, Hyakuna N, et al. Long-term hematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukemia and poor correlation with adult myelodysplasia spliceosome-related mutations. Br J Haematol. 2012;157:647-50.
    • (2012) Br J Haematol. , vol.157 , pp. 647-650
    • Matsuda, K.1    Yoshida, N.2    Miura, S.3    Nakazawa, Y.4    Sakashita, K.5    Hyakuna, N.6
  • 27
    • 48449102092 scopus 로고    scopus 로고
    • The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation
    • Hansen G, Hercus TR, McClure BJ, Stomski FC, Dottore M, Powell J, et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell. 2008;134:496-507.
    • (2008) Cell. , vol.134 , pp. 496-507
    • Hansen, G.1    Hercus, T.R.2    McClure, B.J.3    Stomski, F.C.4    Dottore, M.5    Powell, J.6
  • 28
    • 70349336496 scopus 로고    scopus 로고
    • The granulocyte-macrophage colony-stimulating factor receptor: Linking its structure to cell signaling and its role in disease
    • Hercus TR, Thomas D, Guthridge MA, Ekert PG, King-Scott J, Parker MW, et al. The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood. 2009;114:1289-98.
    • (2009) Blood. , vol.114 , pp. 1289-1298
    • Hercus, T.R.1    Thomas, D.2    Guthridge, M.A.3    Ekert, P.G.4    King-Scott, J.5    Parker, M.W.6
  • 29
    • 0033556176 scopus 로고    scopus 로고
    • Neutrophilic cell production by combination of stem cell factor and thrombopoietin from CD34+ cord blood cells in long-term serum-deprived liquid culture
    • Sawai N, Koike K, Ito S, Mwamtemi HH, Kurokawa Y, Kinoshita T, et al. Neutrophilic cell production by combination of stem cell factor and thrombopoietin from CD34+ cord blood cells in long-term serum-deprived liquid culture. Blood. 1999;93:509-18.
    • (1999) Blood. , vol.93 , pp. 509-518
    • Sawai, N.1    Koike, K.2    Ito, S.3    Mwamtemi, H.H.4    Kurokawa, Y.5    Kinoshita, T.6
  • 30
    • 77955913794 scopus 로고    scopus 로고
    • Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutations
    • Matsuda K, Taira C, Sakashita K, Saito S, Tanaka-Yanagisawa M, Yanagisawa R, et al. Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutations. Blood. 2010;115: 5429-31.
    • (2010) Blood. , vol.115 , pp. 5429-5431
    • Matsuda, K.1    Taira, C.2    Sakashita, K.3    Saito, S.4    Tanaka-Yanagisawa, M.5    Yanagisawa, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.